Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic insights into the admixture and diversity of Kerala crossbred cattle.

Scientific reports·2026
Same author

A Prospective Observational Study in Adult Medical Intensive Care Unit Patients with Drug-Induced QTc with Correlation of Serum Potassium, Magnesium Level of Clinical Outcome.

Journal of pharmacy & bioallied sciences·2025
Same author

Dexmedetomidine vs. midazolam-ketamine for sedation during awake fiberoptic nasal intubation in patients with difficult airway - A randomized, double-blinded, comparative trial.

Journal of anaesthesiology, clinical pharmacology·2025
Same author

Linezolid induced acute toxic leukoencephalopathy and severe thrombocytopenia presenting as stroke mimic-a case report.

Oxford medical case reports·2024
Same author

Surface electromyographic analysis of the bilateral abdomen and back muscle during selected yoga posture.

Journal of bodywork and movement therapies·2024
Same author

An efficient breast cancer classification model using bilateral filtering and fuzzy convolutional neural network.

Scientific reports·2024

Related Experiment Video

Updated: May 10, 2026

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

Human immunodeficiency virus vaccine an update.

Vt Beena1, Kanaram Choudhary, R Rajeev

  • 1Department of Oral and Maxillofacial Pathology, Government Dental College, Trivandrum, Kerala, India.

Journal of Oral and Maxillofacial Pathology : JOMFP
|June 27, 2013
PubMed
Summary

Developing a safe and effective human immunodeficiency virus (HIV) vaccine remains a global health priority. Despite progress, significant challenges hinder HIV vaccine development, including viral variability and immune response complexities.

Keywords:
Acquired immuno deficiency syndromecell mediated immunityhuman immunodeficiency virus vaccine

More Related Videos

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Experiment Videos

Last Updated: May 10, 2026

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Area of Science:

  • Immunology
  • Virology
  • Public Health

Background:

  • The human immunodeficiency virus (HIV) pandemic poses a significant global health threat.
  • Antiretroviral drugs have advanced HIV/AIDS management, but a vaccine is crucial for long-term control.
  • Past vaccine research has faced challenges including viral genetic diversity and lack of clear immune protection indicators.

Purpose of the Study:

  • To review the current status of human immunodeficiency virus (HIV) vaccine research.
  • To summarize key findings and progress in HIV vaccine development.
  • To discuss the primary scientific and logistical challenges impeding the creation of an effective HIV vaccine.

Main Methods:

  • Review of current scientific literature on HIV vaccine research.
  • Analysis of various vaccine strategies and concepts tested to date.
  • Evaluation of challenges in HIV virology, immunology, and clinical trial conduct.

Main Results:

  • Significant advancements in understanding HIV and developing treatments.
  • Multiple vaccine strategies, including DNA, subunit, and vector-based vaccines, have been explored.
  • Persistent challenges include high viral variability, undefined correlates of protection, and animal model limitations.

Conclusions:

  • An effective HIV vaccine is essential for controlling the global pandemic.
  • Overcoming scientific hurdles in viral diversity and immune response is critical.
  • Continued research into novel vaccine platforms and strategies is necessary for future success.